Early Pulmonary Hypertension in Preterm Infants (2023) Srinivasan Mani, MD

Description

This article discusses the unique characteristics and heterogeneous nature of Pulmonary Hypertension (PH) in preterm infants, often linked to hypoxic respiratory failure (HRF). It emphasizes the need for management tailored to the underlying phenotype, noting that specific pulmonary vasodilator therapy is contraindicated in cases of increased pulmonary blood flow or severe cardiac dysfunction. The text also reviews optimized hemodynamic management, recommending alternative inotropes over nonselective vasoconstrictors like dopamine.